EP1287362A4 - Compositions and methods for modulating tumor specific expression - Google Patents

Compositions and methods for modulating tumor specific expression

Info

Publication number
EP1287362A4
EP1287362A4 EP01945989A EP01945989A EP1287362A4 EP 1287362 A4 EP1287362 A4 EP 1287362A4 EP 01945989 A EP01945989 A EP 01945989A EP 01945989 A EP01945989 A EP 01945989A EP 1287362 A4 EP1287362 A4 EP 1287362A4
Authority
EP
European Patent Office
Prior art keywords
compositions
methods
specific expression
tumor specific
modulating tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01945989A
Other languages
German (de)
French (fr)
Other versions
EP1287362A2 (en
Inventor
Thomas A Gardner
Chinghai Kao
Song-Chu Ko
Fan Yeung
Leland W K Chung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UVA Licensing and Ventures Group
University of Virginia UVA
Original Assignee
University of Virginia UVA
University of Virginia Patent Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Virginia UVA, University of Virginia Patent Foundation filed Critical University of Virginia UVA
Publication of EP1287362A2 publication Critical patent/EP1287362A2/en
Publication of EP1287362A4 publication Critical patent/EP1287362A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP01945989A 2000-05-25 2001-05-24 Compositions and methods for modulating tumor specific expression Withdrawn EP1287362A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20790000P 2000-05-25 2000-05-25
US207900P 2000-05-25
PCT/US2001/016944 WO2001090306A2 (en) 2000-05-25 2001-05-24 Compositions and methods for modulating tumor specific expression

Publications (2)

Publication Number Publication Date
EP1287362A2 EP1287362A2 (en) 2003-03-05
EP1287362A4 true EP1287362A4 (en) 2004-05-12

Family

ID=22772429

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01945989A Withdrawn EP1287362A4 (en) 2000-05-25 2001-05-24 Compositions and methods for modulating tumor specific expression

Country Status (6)

Country Link
EP (1) EP1287362A4 (en)
JP (1) JP2004510406A (en)
CN (1) CN1447920A (en)
AU (1) AU2001268087A1 (en)
CA (1) CA2410094A1 (en)
WO (1) WO2001090306A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015277369B2 (en) 2014-06-16 2021-08-19 The Johns Hopkins University Compositions and methods for the expression of CRISPR guide RNAs using the H1 promoter
CN109609505A (en) * 2019-01-14 2019-04-12 中国科学院成都生物研究所 A kind of hammerhead ribozyme of the shearing RNA screened in vivo
JP2022537052A (en) * 2019-06-21 2022-08-23 カーナル バイオロジクス， インコーポレイテッド Engineered tumor-selective protein expression

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972353A (en) * 1992-03-11 1999-10-26 Institute Of Virology, Slovak Academy Of Sciences MN proteins, polypeptides, fusion proteins and fusion polypeptides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972353A (en) * 1992-03-11 1999-10-26 Institute Of Virology, Slovak Academy Of Sciences MN proteins, polypeptides, fusion proteins and fusion polypeptides

Also Published As

Publication number Publication date
CN1447920A (en) 2003-10-08
WO2001090306A3 (en) 2002-04-04
EP1287362A2 (en) 2003-03-05
AU2001268087A1 (en) 2001-12-03
WO2001090306A2 (en) 2001-11-29
CA2410094A1 (en) 2001-11-29
JP2004510406A (en) 2004-04-08

Similar Documents

Publication Publication Date Title
AU6147401A (en) Compositions and methods for the treatment of cancer
IL150819A0 (en) Liver tissue source
AU2140402A (en) Human elongase genes uses thereof and compounds for modulating same
GB0020201D0 (en) Cosmetic Composition
AU2001292864A1 (en) Methods and compositions for modulating angiogenesis
AU2001278338A1 (en) Methods and compositions for modulating tumor growth
AU2002236626A1 (en) Compositions and methods for treating hyperpigmentation
AU7311501A (en) Cosmetic composition and method
EP1476067A4 (en) Novel compositions and methods for cancer
EP1351573A4 (en) Methods for modulating tumor growth and metastasis
EP1509539A4 (en) Novel compositions and methods for cancer
AU6395201A (en) Tumour suppressor and uses thereof
EP1469769A4 (en) Novel compositions and methods for cancer
EP1469870A4 (en) Novel compositions and methods for cancer
EP1287362A4 (en) Compositions and methods for modulating tumor specific expression
HUP0303545A3 (en) Tumor proliferation inhibitors and parmaceutical compositions containing them
EP1370576A4 (en) Methods and compositions for modulating tumor suppression
IL140574A0 (en) Methods and compositions for modulating spermatogenesis
GB0028706D0 (en) Cosmetic composition
AU7373801A (en) Expression modulating sequences
AU148865S (en) Applicator
EP1328298A4 (en) Methods and compositions for modulating t cell activation and uses thereof
GB0003296D0 (en) Applicator
EP1156819A4 (en) Methods and compositions for modulating fertility
AU6627800A (en) Methods and compositions for modulating somatolactogenic functions

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20021218

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20040326

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 07K 14/47 B

Ipc: 7A 61K 48/00 B

Ipc: 7G 01N 33/567 A

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20040504